{
    "clinical_study": {
        "@rank": "26874", 
        "acronym": "TAMAS", 
        "arm_group": [
            {
                "arm_group_label": "true coil", 
                "arm_group_type": "Experimental", 
                "description": "Use the true coil / Low frequency rTMS / Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp"
            }, 
            {
                "arm_group_label": "sham coil", 
                "arm_group_type": "Sham Comparator", 
                "description": "Use the sham coil / Low frequency rTMS / Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to Evaluate Efficacy and Safety of rTMS \u300eTMS\u300f for Upper\n      Extremity Motor Function Recovery in Patients with Ischemic Stroke"
        }, 
        "brief_title": "Efficacy and Safety Study of rTMS for Upper Extremity Motor Function Recovery in Ischemic Stroke Patients", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Hemiplegia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemiplegia", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "Repetitive transcranial magnetic stimulation (rTMS) can modulate the excitability of cortex\n      but exact efficacy and safety of rTMS is not well established.\n\n      Eighty four patients will be recruited and will be divided into two groups. Each group will\n      receive the real rTMS or sham rTMS, respectively, over the primary motor cortex of the\n      dominant hand. Individual subject will receive ten sessions of rTMS. Each rTMS session is\n      low frequency (1Hz), total 1800 stimulations.\n\n      The purpose of this study is to evaluate efficacy and safety of rTMS \u300eTMS\u300f for upper\n      extremity motor function recovery in patients with ischemic stroke."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20-80 yrs old\n\n          -  Radiologically confirmed ischemic stroke within 90 days\n\n          -  Brunnstr\u00f6m stage 3-5 in the affected hand (ischemic stroke-induced hemiplegic side)\n\n          -  Patients received stroke treatment and on secondary prevention medication\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Previous medical histories of stroke, cerebral vascular operation, seizure\n\n          -  Pregnancy, Breastfeeding\n\n          -  Patients with hemorrhagic stroke, traumatic brain injury\n\n          -  Skin lesion in the stimulation site of scalp\n\n          -  Metal implants in the body (cardiac pacemaker or aneurysm clip)\n\n          -  Unable to have regular physical and occupational therapies on the affected hand"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02082015", 
            "org_study_id": "E-1308-214-002"
        }, 
        "intervention": {
            "arm_group_label": [
                "true coil", 
                "sham coil"
            ], 
            "description": "Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp", 
            "intervention_name": "Low frequency rTMS", 
            "intervention_type": "Device", 
            "other_name": "Magpro (low frequency)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Neuronal plasticity", 
            "Transcranial magnetic stimulation", 
            "Stroke", 
            "Upper extremity", 
            "Function", 
            "Recovery"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seongnam-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-707"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind, Sham-Controlled, Multi-center Clinical Trial to Evaluate Efficacy and Safety of rTMS \u300eTMS\u300f for Upper Extremity Motor Function Recovery in Patients With Ischemic Stroke", 
        "other_outcome": {
            "description": "Before rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start", 
            "measure": "Vital Sign", 
            "safety_issue": "Yes", 
            "time_frame": "up to 40 days"
        }, 
        "overall_official": {
            "affiliation": "Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea", 
            "last_name": "Nam-Jong Paik, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Before rTMS (baseline) and 10 days after the completion of 10 sessions of rTMS", 
            "measure": "Box and Block Test (affected hand)", 
            "safety_issue": "No", 
            "time_frame": "up to 17 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02082015"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Nam-Jong Paik", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Before rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start", 
                "measure": "Box and Block Test (Affected and unaffected hand)", 
                "safety_issue": "No", 
                "time_frame": "up to 40 days"
            }, 
            {
                "description": "10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start", 
                "measure": "Barthel Index", 
                "safety_issue": "No", 
                "time_frame": "up to 40 days"
            }, 
            {
                "description": "10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start", 
                "measure": "National Institutes of Health Stroke Scale", 
                "safety_issue": "No", 
                "time_frame": "up to 40 days"
            }, 
            {
                "description": "10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start", 
                "measure": "Fugl-Meyer Assessment Scale", 
                "safety_issue": "No", 
                "time_frame": "up to 40 days"
            }
        ], 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "DongGuk University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}